DelveInsight’s, “Rheumatoid Arthritis Pipeline Insight 2024” report provides comprehensive insights about 95+ companies and 100+ pipeline drugs in Rheumatoid Arthritis pipeline landscape. It covers the Rheumatoid Arthritis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Rheumatoid Arthritis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive […]
Tag: Pharmaceuticals & Biotech
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
Most Active Biotech Stocks Biotech Stocks In Focus: Eli Lilly and Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), Actinium Pharmaceuticals Inc (NYSE: ATNM) Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) is increasingly regarded as a prime acquisition candidate amidst a […]
Neuroblastoma Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Aum Bio, NanoPharma, Athenex, Actuate Therapeutics
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroblastoma pipeline constitutes 35+ key companies continuously working towards developing 35+ Neuroblastoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Neuroblastoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the […]
Spasticity Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight | Arbaclofen ER, SL-1002, Botulinum neurotoxin, MYOBLOC, SPARC1104
Spasticity Market Spasticity companies working in the market are Ipsen Biopharmaceuticals, Inc, RVL Pharmaceuticals, Merz Pharmaceuticals, Allergan, Inc, Jazz Pharmaceuticals, Metacel Pharmaceuticals, Piramal, Amneal Pharmaceuticals, Azurity, Daiichi Pharmaceutical Co., Ltd and many others. (Albany, USA) DelveInsight’s “Spasticity Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Spasticity, historical and forecasted epidemiology as […]
Schizophrenia Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Otsuka Pharma, Gedeon Richter Ltd., Lyndra Therapeutics, Neurocrine Bioscience, Takeda
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Schizophrenia pipeline constitutes 70+ key companies continuously working towards developing 70+ Schizophrenia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Schizophrenia Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario […]
Urea Cycle Disorders Market to Register Sustainable Growth During the Forecast Period | Acer Therapeutics, Dimension Therapeutics, Callitas Therapeutics, Poseida Therapeutics, Promethera Biosciences
Urea Cycle Disorders Market The Urea Cycle Disorders therapeutics market is anticipated to grow in the coming years owing to the increasing incidence of Urea Care Disorders patients in the 7MM and the launch of the emerging therapies. Some of the key companies such as ACER-001 (Acer Therapeutics), AEB1102(Aeglea BioTherapeutics), DTX301 (Ultragenyx Pharmaceutical), among others […]
Remote Patient Monitoring Market Worth $41.7 Billion: Trends, Opportunities, and Challenges in the Healthcare Landscape
Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to the prevalence of chronic diseases, subsequent overcrowding in hospitals, rising geriatric population, growth opportunities for advanced internet-based platforms in the RPM, favourable government policies, the rising need to curtail healthcare expenditure, and increasing consumer awareness of health-related […]
Eosinophilic Asthma Market Forecast 2032: Clinical Trials, Epidemiology, Therapies, FDA, EMA, PDMA Approvals and Companies by DelveInsight| OC000459, GSK3511294, Masitinib, ANB020, Reslizumab, Dexpram
Eosinophilic Asthma Market Eosinophilic Asthma companies are AstraZeneca, AB Science, Cheisi Pharmaceuticals, Teva Pharmaceuticals, Arteria Therapeutics, Knopp Biosciences, GlaxsoSmithKline, Novartis, And many others. (Albany, USA) DelveInsight’s “Eosinophilic Asthma Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Eosinophilic Asthma, historical and forecasted epidemiology as well as the Eosinophilic Asthma market trends in […]
Polymyositis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Argenx, Immunoforge Co. Ltd., Chester Oddis, Paean Biotechnology Inc., Kezar
The Polymyositis Market size was valued approximately USD 88 million in 2020 and the report offers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as the Polymyositis market trends in the 7MM. DelveInsight’s “Polymyositis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Polymyositis, historical and forecasted […]
Hypoparathyroidism Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight | TRANSCON PTH (palopegteriparatide), Eneboparatide (AZP-3601)
Hypoparathyroidism Market Hypoparathyroidism companies are Ascendis Pharma, Amolyt Pharma, Bridgebio, Calcilytix Therapeutics, Aerami Therapeutics Inc, Aeterna Zentaris Inc, BridgeBio Pharma Inc, Eli Lilly, Entera Bio Ltd, Extend Biosciences, GC Biopharma Corp, MBX Biosciences Inc, ProLynx, Rani Therapeutics and others. (Albany, USA) DelveInsight’s “Hypoparathyroidism Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of […]